This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n7http://linked.opendata.cz/resource/drugbank/drug/DB01865/identifier/pubchem-substance/
n8http://linked.opendata.cz/resource/drugbank/drug/DB01865/identifier/drugbank/
n13http://bio2rdf.org/drugbank:
n11http://linked.opendata.cz/resource/drugbank/drug/DB01865/identifier/chemspider/
admshttp://www.w3.org/ns/adms#
n15http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
n9http://linked.opendata.cz/resource/drugbank/drug/DB01865/identifier/pdb/
xsdhhttp://www.w3.org/2001/XMLSchema#
n10http://linked.opendata.cz/resource/drugbank/drug/DB01865/identifier/bindingdb/
n6http://linked.opendata.cz/resource/drugbank/drug/DB01865/identifier/pubchem-compound/

Statements

Subject Item
n2:DB01865
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n13:DB01865 n15:DB01865
dcterms:title
3-(6-Aminopyridin-3-Yl)-N-Methyl-N-[(1-Methyl-1h-Indol-2-Yl)Methyl]Acrylamide
adms:identifier
n6:5287720 n7:46506837 n8:DB01865 n9:AYM n10:8720 n11:4450032
n3:IUPAC-Name
n4:271B4E4E-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4E54-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4E53-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4E50-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4E51-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4E52-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B4E4C-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B4E4A-363D-11E5-9242-09173F13E4C5 n4:271B4E4D-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B4E4B-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B4E5A-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B4E5B-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4E55-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4E56-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4E58-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4E57-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B4E59-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B4E5F-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4E61-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4E62-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4E5E-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B4E5D-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4E60-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4E4F-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B4E5C-363D-11E5-9242-09173F13E4C5